Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug

STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug
ShareXFacebook

Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

The Case Against Calling It 'Emergency Medicine'
MedPage Today

The Case Against Calling It 'Emergency Medicine'

(MedPage Today) -- Names matter. They shape expectations, guide behavior, and in medicine, determine how systems are built, how resources are allocated, and how clinicians practice. The name "emergency medicine" is one of the most consequential...

Read more →
Advertisement